Search research articles
Contact Us
Filters
Showing results (171-180 of 252) with videos related to
Page
of 26
Sort By:
Frontiers in Cellular and Infection Microbiology
|
August 27, 2021
An Extracellular Redox Signal Triggers Calcium Release and Impacts the Asexual Development of <i>Toxoplasma gondii</i>
Eduardo Alves, Henry J Benns, Lilian Magnus, et al.
American Journal of Human Genetics
|
February 11, 1999
Mapping of primary congenital lymphedema to the 5q35.3 region
A L Evans, G Brice, V Sotirova, et al.
Journal of Inorganic Biochemistry
|
April 20, 2023
Selective carbon-hydrogen bond hydroxylation using an engineered cytochrome P450 peroxygenase
Jinia Akter, Tegan P Stockdale, Stella A Child, et al.
Australian Health Review : a Publication of the Australian Hospital Association
|
December 9, 1994
As good as anyone: antenatal shared care at an inner Sydney hospital
P Webster, B Ulmer, J Mann, et al.
British Journal of Haematology
|
January 14, 1999
True spectrum of 14q32 translocations in multiple myeloma
G Pratt, J A Fenton, J A Proffitt, et al.
British Journal of Cancer
|
November 1, 1982
An investigation of factors influencing serum NCA (non-specific cross-reacting antigen) level in patients with chronic myeloid leukaemia
N Frénoy, M Ben-Bunant, C Berruel, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 1, 1992
Two mutations in Marfan syndrome resulting in truncated fibrillin polypeptides
K Kainulainen, L Y Sakai, A Child, et al.
Clinical Lymphoma
|
November 15, 2001
Clinicopathological correlates of IgM paraproteinemias
R G Owen, L A Parapia, J Higginson, et al.
Hematological Oncology
|
November 1, 1992
A pilot study of ChlOPhEPP-B--a weekly regimen for patients with untreated advanced or recurrent Hodgkin's disease
G M Smith, D Wright, J A Child, et al.
Hematological Oncology
|
December 1, 1996
A phase I trial to assess the value of recombinant human granulocyte colony stimulating factor (R-MeTHuG-CSF, filgrastim) in accelerating the dose rate of chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma (NHL). The Central Lymphoma Group
G M Smith, J A Child, M H Cullen, et al.
Page
of 26
Search research articles
Search
Showing results (171-180 of 252) with videos related to
Sort By:
Page
of 26
Frontiers in Cellular and Infection Microbiology
|
August 27, 2021
An Extracellular Redox Signal Triggers Calcium Release and Impacts the Asexual Development of <i>Toxoplasma gondii</i>
Eduardo Alves, Henry J Benns, Lilian Magnus, et al.
American Journal of Human Genetics
|
February 11, 1999
Mapping of primary congenital lymphedema to the 5q35.3 region
A L Evans, G Brice, V Sotirova, et al.
Journal of Inorganic Biochemistry
|
April 20, 2023
Selective carbon-hydrogen bond hydroxylation using an engineered cytochrome P450 peroxygenase
Jinia Akter, Tegan P Stockdale, Stella A Child, et al.
Australian Health Review : a Publication of the Australian Hospital Association
|
December 9, 1994
As good as anyone: antenatal shared care at an inner Sydney hospital
P Webster, B Ulmer, J Mann, et al.
British Journal of Haematology
|
January 14, 1999
True spectrum of 14q32 translocations in multiple myeloma
G Pratt, J A Fenton, J A Proffitt, et al.
British Journal of Cancer
|
November 1, 1982
An investigation of factors influencing serum NCA (non-specific cross-reacting antigen) level in patients with chronic myeloid leukaemia
N Frénoy, M Ben-Bunant, C Berruel, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 1, 1992
Two mutations in Marfan syndrome resulting in truncated fibrillin polypeptides
K Kainulainen, L Y Sakai, A Child, et al.
Clinical Lymphoma
|
November 15, 2001
Clinicopathological correlates of IgM paraproteinemias
R G Owen, L A Parapia, J Higginson, et al.
Hematological Oncology
|
November 1, 1992
A pilot study of ChlOPhEPP-B--a weekly regimen for patients with untreated advanced or recurrent Hodgkin's disease
G M Smith, D Wright, J A Child, et al.
Hematological Oncology
|
December 1, 1996
A phase I trial to assess the value of recombinant human granulocyte colony stimulating factor (R-MeTHuG-CSF, filgrastim) in accelerating the dose rate of chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma (NHL). The Central Lymphoma Group
G M Smith, J A Child, M H Cullen, et al.
Page
of 26